In her role as Chief Advocacy Officer at Canopy Growth, Hilary is responsible for driving patient advocacy efforts worldwide, executing the Company’s social purpose strategy including social justice initiatives, and co-leading the implementation of best practices for diversity & inclusion. In 1997, Hilary founded the British Columbia Compassion Club Society (BCCCS), the first medical cannabis dispensary in Canada. In addition to providing medical cannabis therapies, the BCCCS offers subsidized natural healthcare services in its Wellness Centre, dramatically improving the health and quality of life for thousands of critically and chronically ill Canadians. She has been dedicated to serving patients for over 20 years and continues to be committed to breaking down the barriers to access to medical cannabis for all Canadian patients. She championed an initiative focusing on the role of cannabis in addressing the opioid overdose crisis and other substance use disorders. Canopy Growth donated $2.5 million to the University of British Columbia, and the BC Ministry of Mental Health and Addiction donated an additional $500,000 to establish the Canopy Growth Professorship of Cannabis Science which will examine the potential utility of cannabis in addressing the opioid crisis. Mr. Rands is a qualified patent attorney in the UK and Europe with over 10 years’ experience in the pharmaceutical industry. Mr. Rands has always had a passion for pharmaceutical innovation. Mr. Rands graduated from the University of Oxford in 2003 with a first class degree in Chemistry, following which he trained and qualified as a UK and European patent attorney specializing in pharmaceuticals. Tim Moore is the CEO of Havn Life Sciences Inc. Shadd Dales is the CEO of The Dales Report.